Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $516.00K in the quarter ending March 31, 2026, a decrease of -99.47%. This brings the company's revenue in the last twelve months to $23.14M, down -88.41% year-over-year. In the year 2025, Atara Biotherapeutics had annual revenue of $120.77M, down -6.33%.

• Revenue (ttm): $23.14M
• Revenue Growth: -88.41%
• P/S Ratio: 3.61
• Revenue / Employee: $1,652,786
• Employees: 14
• Market Cap: 79.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	120.77M	-8.17M	-6.33%
Dec 31, 2024	128.94M	120.37M	1,404.02%
Dec 31, 2023	8.57M	-55.00M	-86.51%
Dec 31, 2022	63.57M	43.23M	212.55%
Dec 31, 2021	20.34M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error